SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-24-011270
Filing Date
2024-03-14
Accepted
2024-03-14 17:19:06
Documents
128
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K akba-20231231.htm   iXBRL 10-K 3170275
2 EX-4.7 akbaex47formofwarrant.htm EX-4.7 126634
3 EX-10.21 akbaex1021thirdamendedandr.htm EX-10.21 29107
4 EX-10.43 akbaex1043akbaesa-elt52019.htm EX-10.43 85199
5 EX-10.44 akbaex1044akebia-formofcas.htm EX-10.44 16519
6 EX-10.45 akbaex10452023planformofof.htm EX-10.45 56897
7 EX-10.46 akbaex1046akebia-2023planf.htm EX-10.46 66058
8 EX-10.47 akbaex1047formofofficerind.htm EX-10.47 55842
9 EX-10.66 akbaex1066hadas_nicolexame.htm EX-10.66 7912
10 EX-10.67 akbaex1067dahan_michelxame.htm EX-10.67 7301
11 EX-10.93 akbaex1093akebiapharmakonf.htm EX-10.93 76316
12 EX-10.102 akbaex10102akebia_kreosxcr.htm EX-10.102 540637
13 EX-10.103 akbaex10103kreos-akebiaxwa.htm EX-10.103 52296
14 EX-23.1 akbaex231-eyakebiaconsent.htm EX-23.1 9203
15 EX-31.1 akbaex31112312023-10xk.htm EX-31.1 10893
16 EX-31.2 akbaex31212312023-10xk.htm EX-31.2 10929
17 EX-32.1 akbaex32112312023-10xk.htm EX-32.1 8766
18 EX-97.1 akbaex971-akbanasdaqcompli.htm EX-97.1 20634
24 GRAPHIC akba-20231231_g1.gif GRAPHIC 3995
25 GRAPHIC image_0.jpg GRAPHIC 13424
26 GRAPHIC image_01.jpg GRAPHIC 13424
27 GRAPHIC image_1.jpg GRAPHIC 16805
28 GRAPHIC image_11.jpg GRAPHIC 16805
29 GRAPHIC image_2.jpg GRAPHIC 1462
30 GRAPHIC image_21.jpg GRAPHIC 1461
31 GRAPHIC image_3.jpg GRAPHIC 1261
32 GRAPHIC image_31.jpg GRAPHIC 1265
  Complete submission text file 0001628280-24-011270.txt   14061889

Data Files

Seq Description Document Type Size
19 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT akba-20231231.xsd EX-101.SCH 104230
20 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT akba-20231231_cal.xml EX-101.CAL 100097
21 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT akba-20231231_def.xml EX-101.DEF 456533
22 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT akba-20231231_lab.xml EX-101.LAB 1058492
23 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT akba-20231231_pre.xml EX-101.PRE 748879
130 EXTRACTED XBRL INSTANCE DOCUMENT akba-20231231_htm.xml XML 1501737
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36352 | Film No.: 24751308
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)